Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

60 results about "KANAMYCIN SULFATE" patented technology

Kanamycin Sulfate is a water-soluble antibiotic originally purified from the bacterium Streptomyces kanamyceticus. Kanamycin acts by binding to the 30S subunit of the bacterial ribosome and inhibiting protein synthesis in susceptible bacteria.

Compound ofloxacin injection for animals for treating postnatal infection and preparation method thereof

The invention discloses a compound ofloxacin injection for animals for treating postnatal infection and a preparation method thereof. The invention aims to provide a compound ofloxacin injection for the animals which has quick response on treating the postnatal infection of livestock, is effective and efficient and can treat both principal and secondary aspects of diseases, and a preparation method thereof. Each 100L of injection comprises the following components: 0.5 to 10kg of ofloxacin, 3 to 15 of billion units of kanamycin sulfate, 0.06kg of dexamethasone sodium phosphate, 0.02 to 0.1kg of bethanechol chloride, 1,000ml of hydrochloric acid, and the balance of water for injection. The injection has double functions of bacteria inhibition and sterilization by using the ofloxacin in combination with the kanamycin sulfate, reduces the probability that bacteria produce the drug resistance, and increases the sensitivity of the bacteria; in addition, the dexamethasone sodium phosphate has anti-inflammatory, detoxicating and antiallergic functions; and the bethanechol chloride stimulates the intestines and stomach as well as uterine smooth muscle to creep. The product treats both principal and secondary aspects of diseases on the postnatal infection of dams and complicating diseases thereof, and can accelerate the postpartum recovery of the dams.
Owner:天津市海纳德动物药业有限公司

Antibody reagent preserving fluid

The invention discloses an antibody reagent preserving fluid which comprises ingredients such as sodium chloride, dipotassium phosphate, sodium dihydrogen phosphate, kanamycin sulfate, bovine serum albumin and SOD(Superoxide Dismutase). All the ingredients in the preserving fluid are matched with each other rationally and advantageous for the preservation of antibodies, in particular monoclonal antibodies for blood grouping, and as a result, the preservation period of the monoclonal antibodies at the normal temperature is longer and can be up to 2 years. The antibody reagent preserving fluid is capable of an appropriate environment for preserving the antibody reagent, and also solves the problem that the antibody reagent cannot be preserved for a long time at the room temperature. The antibody reagent preserved with the antibody reagent preserving fluid is applied to the production of a microcolumn gel immunodetection reagent card so that long-term preservation of the microcolumn gel immunodetection reagent card at the normal temperature can be realized, and therefore, the gel immunodetection reagent card can be widely applied.
Owner:CHANGCHUN BIOXUN BIOTECH CO LTD

Preparation method of synergistic tylosin tartrate soluble powder compound medicine

The invention aims at providing a preparation method of a synergistic tylosin tartrate soluble powder compound medicine. The synergistic tylosin tartrate soluble powder compound medicine has a rapid and definite curative effect on respiratory system infections and complications of livestock and poultry. The preparation method comprises the following steps of: mixing 0.2 part of trimethoprim and 0.2 part of cosolvent, then crushing, and sieving by using a 120 meshes sieve or a finer sieve; and then uniformly mixing with 1 part of tylosin tartrate, 1 part of kanamycin sulfate and 0.05-0.1 part of pain alleviant by an equivalently successive increase method, thus obtaining the synergistic tylosin tartrate soluble powder compound medicine. The cosolvent is citric acid or succinic acid or the mixture of citric acid and succinic acid and the pain alleviant is procaine hydrochloride or lidocaine hydrochloride or the mixture of procaine hydrochloride and lidocaine hydrochloride. The animal synergistic tylosin tartrate soluble powder compound medicine for injection contains three medical components which are tylosin tartrate, kanamycin sulfate and trimethoprim, can be used for solving the problems that the secondary infection cannot be controlled very well during the treatment of mycoplasma infection due to the narrow antibacterial spectrum of the tylosin tartrate, and the trimethoprim is insoluble in water, has a synergistic effect on tylosin tartrate and kanamycin sulfate and has an obvious medicine curative effect.
Owner:四川联美生物药业有限公司

Compound kanamycin sulfate injection liquid for pig and preparation method thereof

The invention discloses a compound kanamycin sulfate injection liquid for a pig and a preparation method thereof, aiming at providing a compound kanamycin sulfate injection liquid which has fast effect for treating pant disease of the pig, addresses both the symptoms and root causes, reduces the time and dosage of taking drug and has convenient drug usage, and a preparation method with simple technique and easy implementation. Each 100L injection liquid comprises: 5 to 20 billion units of kanamycin monosulfate, 1 to 10kg of lincomycin hydrochloride, 0.1 to 2kg of doxofylline, 0.05kg of dexamethasone sodium phosphate, 0.2kg of sodium bisulfite, 0.01kg of EDTA-2Na, 10kg of dimethyl acetamide and the balance of water for injection. The injection liquid reasonably mixes usage of all the components by a plurality of types of drugs, has fast effect for treating pant disease of the pig, addresses both the symptoms and root causes, reduces drug resistance of pathogenic microorganism and leads the pig to accelerate restoring. Simultaneously, the compound kanamycin sulfate injection liquid has convenient use, and can achieve the treatment effect of a plurality of types of drugs.
Owner:TIANJIN SHENGJI GRP CO LTD

Compound lincomycin hydrochloride injection and reparation method thereof

The invention relates to compound lincomycin hydrochloride injection and a preparation method thereof. The preparation method comprises the following steps: (1) adding aminopyrine and prednisolone acetate into 95% ethanol and stirring for 10-25 min until the solution is clear; (2) fetching 300 L of injection water, adding kanamycin sulfate and lincomycin hydrochloride in turn and stirring for dissolution; and (3) mixing the solutions obtained in steps (1) and (2), adding injection water until the solution volume is 1,000 L, uniformly stirring and maintaining for 15-20 min until the liquid medicine is clear to obtain the compound lincomycin hydrochloride injection. The invention has the advantages that the compound preparation of kanamycin sulfate and lincomycin hydrochloride, the aminopyrine with adjuvant therapy effect and prednisolone acetate with adjuvant therapy effect are adopted and combined for use, thus achieving antibacterial action on gram-negative bacteria and gram-positive bacteria due to the joint application of the four medicines; and the antimicrobial spectrum is wide, the antimicrobial range is expanded, pig paratyphus and certain complications can be comprehensively treated, the curative effect is good and quick, the drug resistance rate of bacteria is reduced and the curative effect is enhanced.
Owner:TIANJIN BIJIA PHARMA CO LTD

Preparation method of medicine for treating respiratory system infection of livestock and poultry

The invention aims at providing a preparation method of a medicine for treating respiratory system infection of livestock and poultry. The medicine has rapid and accurate treatment effects on respiratory system infection and complications of livestock and poultry. The medicine is prepared by the following steps: mixing and crushing 0.2 part of trimethoprim and 0.2 part of a cosolvent, and then sieving the mixture through a 120-mesh sieve or a finer sieve; and uniformly mixing the sieved product with 1 part of tylosin tartrate, 1 part of kanamycin sulfate and 0.05-0.1 part of a pain reliever by a method of progressively increasing by equal quantity, wherein the cosolvent is citric acid, succinic acid or a compound of the two, and the pain reliever is procaine hydrochloride, lidocaine hydrochloride or a compound of the two. The synergism compound tylosin tartrate for livestock injection provided by the invention contains three components, namely the tylosin tartrate, kanamycin sulfate and trimethoprim; the problem that secondary infection cannot be well controlled due to the narrow antibacterial spectrum of the tylosin tartrate when mycoplasma infection is treated can be solved; the problem that the trimethoprim is poorly soluble in water can be solved, a synergism effect of the tylosin tartrate and kanamycin sulfate can be achieved, and the medicine has an obvious treatment effect.
Owner:SICHUAN DERUNTONG BIOTECH

Compound synergistic tylosin tartrate

The invention relates to a compound synergistic tylosin tartrate. The invention aims to provide an compound synergistic tylosin tartrate for injection for livestock, which has quick and definite curative effect on livestock and fowl respiratory system infections and complications. The medicine is composed of the following components in parts by weight: 1 part of tylosin tartrate, 1 part of kanamycin sulfate, 0.2 part of trimethoprim, 0.2 part of cosolvent and 0.05-0.1 part of pain relieving agent. The cosolvent is citric acid or succinic acid or compound of both, and the pain relieving agent is procaine hydrochloride or lidocaine hydrochloride or compound of both. The compound synergistic tylosin tartrate for injection for livestock contains the three pharmaceutical components, including tylosin tartrate, kanamycin sulfate and trimethoprim. The invention solves the problem of incapability of well controlling the secondary infection due to the narrow antimicrobial spectrum of the tylosin tartrate in treating mycoplasma infection, solves the problem of insolubility of trimethoprim in water, has a synergistic effect on tylosin tartrate and kanamycin sulfate, and is accurate in dosage and convenient to use.
Owner:金河牧星(重庆)生物科技有限公司

Compound synergistic tartaric acid tylosin for injection of livestock

The invention relates to a compound synergistic tartaric acid tylosin for injection of livestock and aims at providing a compound synergistic tartaric acid tylosin, which can be used for achieving a rapid and definite curative effect on the breathing system infection and complications of livestock, for injection of livestock. The medicine comprises the following components in parts by weight: 1 part of tartaric acid tylosin, 1 part of kanamycin sulfate, 0.2 parts of trimethoprim, 0.2 parts of cosolvent and 0.05-0.1 parts of pain alleviator, wherein the cosolvent is citric acid or succinic acid or a combination of the citric acid and the succinic acid; and the pain alleviator is procaine hydrochloride or lidocaine hydrochloride or a combination of procaine hydrochloride and the lidocaine hydrochloride. The compound synergistic tartaric acid tylosin for injection of livestock contains medicine components of three types, namely tartaric acid tylosin, kanamycin sulfate and trimethoprim, can be used for solving the problems that tartaric acid tylosin is narrow in antimicrobial spectrum and cannot well control secondary infection during the treatment of mycoplasma infection and the problem that trimethoprim is insoluble in water, and achieving a synergy effect on tartaric acid tylosin and kanamycin sulfate, and is accurate in dosage and convenient in use.
Owner:SICHUAN DERUNTONG BIOTECH

Method for simultaneously detecting emergence rate and insect resistance purity of transgenic Bt insect-resistant cottonseeds

The invention discloses a method for simultaneously detecting the emergence rate and insect resistance purity of transgenic Bt insect-resistant cottonseeds. The method is characterized by comprising the following steps of: (1) preparing a kanamycin sulfate aqueous solution with concentration between 0.4 and 0.6 percent; (2) preparing wet sand; (3) sowing; and (4) culturing. Under a selective pressure applicable to antibiotics, the method adopts a mechanism that a product which is encoded with a neomycin phosphotransferase (npt II) gene carried by a transgenic Bt plant as a label can inactivate kanamycin sulfate and other aminoglycoside antibiotics to grow normally, but a non-transgenic Bt plant does not contain an npt II gene serving as a label and cannot grow normally, so that the insect resistance purity can be detected while the emergence rate of the transgenic Bt insect-resistant cottonseeds is detected. The method is easy and practical and is low in cost, and the detection accuracy of the method can be 100 percent.
Owner:COTTON RES INST HEBEI ACAD OF AGRI & FOREST SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products